Navigation Links
Hospira Reports Second-Quarter 2011 Results
Date:7/27/2011

including projections of certain measures of Hospira's results of operations, projections of certain charges and expenses, cash flow and other statements regarding Hospira's goals and strategy. Hospira cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, regulatory, legal, technological and other factors that may affect Hospira's operations and may cause actual results to be materially different from expectations include the risks, uncertainties and factors discussed under the headings "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Hospira's latest Annual Report on Form 10-K and subsequent Forms 10-Q, filed with the Securities and Exchange Commission, which are incorporated by reference. Hospira undertakes no obligation to release publicly any revisions to forward-looking statements as the result of subsequent events or developments.

Hospira, Inc.Condensed Consolidated Statements of Income(Unaudited)(dollars and shares in millions, except for per share amounts)Three Months Ended June 30,% Change20112010Net sales $
,064.1 $
968.2 9.9%Cost of products sold50.7 599.0 8.6%Restructuring, impairment and (gain) on disposition of assets, net.5 2.6 (42.3)%Research and development5.8 80.4 (18.2)%Selling, general and administrative55.6 9.9 (8.4)%Total operating costs and expenses873.6 851.9 2.5%Income From Operations90.5 .3 63.8%Interest expense23.9 24.2 (1.2)%Other income, net(2.0)(0.3)566.7%Income Before Income Taxes8.6 92.4 82.5%Income tax expense36.7 9.4 290.4%Equity income from affiliates, net(11.7)(0.5)nmNet Income $
43.6 $
83.5 72.0%Earnings Per Common Share:Basic $
.86 $
.50 72.0%Diluted $
.85 $
.49 73.5%Weighted Average Common Shares Outstanding:Basic
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Hospira to Host Conference Call for Second-Quarter 2011 Results
2. Hospira Receives Health Canada Regulatory Approval for Symbiq™ Infusion System Software Upgrade
3. Hospira to Present at the Sanford C. Bernstein Twenty-Seventh Annual Strategic Decisions Conference 2011
4. Hospira Highlights Progress in 2010 at Its 2011 Annual Meeting of Shareholders
5. Hospira Reports First-Quarter 2011 Results
6. Hospira Board Authorizes $1 Billion Share Repurchase Program
7. Hospira to Present at Bank of America / Merrill Lynch 2011 Health Care Conference May 11, 2011
8. Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial Resistance
9. Hospira to Host Conference Call for First-Quarter 2011 Results
10. Hospira Submits 510(k) Application to FDA for Symbiq™ Infusion System Modifications
11. Hospira Launches Enhanced TheraDoc™ Clinical Surveillance System to Support Patient Safety and Help Improve Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015 ... addition of the "Investigation Report on China,s ... offering. Developed by Novo Nordisk, insulin ... an important drug for the treatment of diabetes. ... fast- acting insulin analog, starts working fast and ...
(Date:8/28/2015)... August 28, 2015 The scientific team ... with one of the leading academics in the field of ... record holder in life extension for model animals - 10 ... of aging and age-related diseases, primarily, around the stability and ... just been published as "Stability analysis of a model gene ...
(Date:8/28/2015)... 28, 2015  Perrigo Company plc ("Perrigo") (NYSE: ... the acquisition of leading OTC brands from GSK in ... transaction is a clear demonstration of Perrigo,s unique ability ... distribution network spanning 36 countries.  Perrigo ... commented, "We are excited to complete this transaction, which ...
Breaking Medicine Technology:China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4
... 27 Puroast(R) Low Acid Coffee,has conducted both ... its great tasting, gourmet coffee provides symptom relief ... brew. Puroast(R) achieves,this without extractions, substitutes or additives; ... full-bodied taste., Prior chemistry research at University ...
... Emerging Data Shows Encouraging Response in CF Patients ... BETHESDA, Md., March 27 The Cystic Fibrosis ... that targets a,basic defect in CF, showed promising results ... carry the G551D mutation of CF. The drug is,being ...
Cached Medicine Technology:Low Acid Coffee Backed By Scientific Research 2Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF 2Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF 3
(Date:8/29/2015)... ... August 29, 2015 , ... Targeted therapies, made possible ... lives of patients, according to a newly published report. Surviving Mesothelioma has more ... article. , The authors of the new paper focus on several types ...
(Date:8/29/2015)... ... 2015 , ... Brands like Toppik , Eau Thermale Avene and Bliss ... a threshold of $49.00 was required to qualify for free standard shipping,” said Jennifer ... shipping for customers regardless of the item’s selling price.” , With competitive pricing in ...
(Date:8/29/2015)... ... ... ProDrop Particles includes over 40 particle backdrops designed for use in ... users can shrink and stretch in the Final Cut Pro X timeline. Choose from ... scale, speed, range, and flare attributes with intuitive controls found in the top-right inspector ...
(Date:8/29/2015)... New York, NY (PRWEB) , ... August 29, ... ... consistently successful results and include treating the localized area with stretching, soft tissue ... and a neutral pelvic position have shown through research to improve treatment ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... freely market and sell Arterosil and Arterosil HP, and that all claims and ... sued Vascular Health Sciences, LLC (VHS) in the United States District Court for ...
Breaking Medicine News(10 mins):Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3
... this New Digest: , , Summary of ... the Journal of Clinical Oncology ,showing no ... cancer whose ovaries were left intact during cancer ... removed., Quote for attribution from Beth Karlan, MD, ...
... and Spanish . , A research work carried ... University of Granada has carried out an analysis of the ... most of them belong to the group of lactic bacteria, which ... for health. The doctoral thesis by Antonio M. Martn Platero ...
... High-Quality Care to Homeless Animals and the Public, Regardless ... Spay/Neuter 12,000 Cats and Dogs in 2009 -- Double ... The San Francisco SPCA today announced the opening of ... home of its nonprofit Veterinary Hospital, Spay/Neuter Clinic and ...
... Collaborate and Achieve ComplianceHOPKINTON, Mass., Jan. 28 ... world leader in information infrastructure solutions, today announced ... (DCM) to centrally store, review, approve and manage ... procedures (SOPs). As a result, RadPharm has ...
... Sunday throughout February, Sharing Miracles , a 30-minute ... inspirational stories of real patients, will feature television actress ... the hit sitcom Family Ties . Sharing ... across the United States. Though perhaps best known for ...
... Swiss Re,s Employer Stop Loss insurance coverage is ... in self-funding their employee health plans in the United ... liability and benefit from self-funding their employee health plans. ... in all 50 states and the District of Columbia ...
Cached Medicine News:Health News:Study shows younger women with endometrial cancer can safely keep ovaries, avoid early menopause 2Health News:Most bacteria from craft goat's cheese come from lactic acid and could be beneficial for health 2Health News:San Francisco SPCA Dramatically Expands Charitable Veterinary Care With Opening of Leanne B. Roberts Animal Care Center 2Health News:San Francisco SPCA Dramatically Expands Charitable Veterinary Care With Opening of Leanne B. Roberts Animal Care Center 3Health News:San Francisco SPCA Dramatically Expands Charitable Veterinary Care With Opening of Leanne B. Roberts Animal Care Center 4Health News:RadPharm Finds Cure to Efficiently Manage Regulated Documents with EMC 2Health News:RadPharm Finds Cure to Efficiently Manage Regulated Documents with EMC 3Health News:'Sharing Miracles' Television Program to Feature Emmy Award-Nominated Actress Meredith Baxter 2Health News:'Sharing Miracles' Television Program to Feature Emmy Award-Nominated Actress Meredith Baxter 3Health News:'Sharing Miracles' Television Program to Feature Emmy Award-Nominated Actress Meredith Baxter 4Health News:'Sharing Miracles' Television Program to Feature Emmy Award-Nominated Actress Meredith Baxter 5Health News:'Sharing Miracles' Television Program to Feature Emmy Award-Nominated Actress Meredith Baxter 6Health News:'Sharing Miracles' Television Program to Feature Emmy Award-Nominated Actress Meredith Baxter 7Health News:Swiss Re's Employer Stop Loss Product Offers US Companies Cost Savings for Self-Funded Health Insurance Plans 2Health News:Swiss Re's Employer Stop Loss Product Offers US Companies Cost Savings for Self-Funded Health Insurance Plans 3
... This comfortable pre-fabricated orthosis is designed ... distal third humeral diaphyseal fractures. The ... circumferential soft tissue compression for optimal ... range-of- motion of both shoulder and ...
... comfortable pre-fabricated orthosis is designed for ... third humeral diaphyseal fractures. The lightweight ... soft tissue compression for optimal control ... range-of-motion of both the shoulder and ...
Controls humeral segments through soft tissue compression while allowing for full range of elbow motion...
... Splint is indicated for the treatment of ... economical and easy to apply. The splint ... dorsiflexion, limiting nightly contractures and tightening of ... feature permits flexibility in the treatment of ...
Medicine Products: